MDMeggie M. C. M. Drissen

Meggie M. C. M. Drissen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Meggie M. C. M. Drissen has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Experience in a PHTS Expertise Centre: Yield of Thyroid Ultrasound Surveillance in Children with PTEN Hamartoma Tumor Syndrome

    by Esther M.G. Bormans, Janneke H.M. Schuurs-Hoeijmakers, Petra van Setten, Linda A.J. Hendricks, Meggie M.C.M. Drissen, Martin Gotthardt, Hedi L. Claahsen-Van der Grinten, Nicoline Hoogerbrugge, Jolanda H. Schieving

    Children with PTEN hamartoma tumor syndrome (PHTS) are at increased risk for developing thyroid abnormalities, including differentiated thyroid carcinoma (DTC). The Dutch PHTS guideline recommends ultrasound surveillance starting from age 18. Since the literature describes PHTS patients who developed DTC before age 18, the Dutch PHTS expertise centre has initiated annual ultrasound surveillance starting from age 12. The purpose of this study was to identify the yield of thyroid ultrasound surveillance in children. A retrospective single centre cohort study was conducted. Pediatric PHTS patients who received thyroid ultrasound surveillance before age 18 between 2016-2023 were included. Patients' medical records have been reviewed. Primary outcomes included prevalence and time to develop thyroid nodules ≥10mm, nodular growth, goiter, thyroiditis and DTC. Descriptive statistics and Kaplan-Meier analyses were performed. Forty-three patients were included. Two patients (5%) were diagnosed with DTC at ages 12 and 17. Both DTCs were identified as minimally invasive follicular carcinoma at stages pT3NxMx and pT1NxMx respectively. A total of 84% were diagnosed with thyroid abnormalities at a median age of 12 years (range 9-18). Most common findings were benign, including nodular disease (74%), goiter (30%) and autoimmune thyroiditis (12%). Nodular growth was observed in 14 patients (33%) resulting in (hemi)thyroidectomy in 7 patients (16%). Thyroid ultrasound surveillance resulted in the detection of DTC in 2/43 PHTS patients before age 18. These findings support the recommendation to initiate thyroid ultrasound surveillance in children at least from age 12, preferably within an expertise centre.


  • Open Access

    Increased frequency of infections and autoimmune disease in adults with PTEN Hamartoma Tumour Syndrome

    by Meggie M.C.M. Drissen, Janet R. Vos, Estel Collado Camps, Janneke H.M. Schuurs-Hoeijmakers, Jolanda H. Schieving, Nicoline Hoogerbrugge


  • Open Access

    Neuropsychological functioning of adults with PTEN hamartoma tumor syndrome

    by Carmen Oldenboom, Meggie M. C. M. Drissen, Linde C. M. van Dongen, Tjitske Kleefstra, Judith B. Prins, Jos I. M. Egger, Nicoline Hoogerbrugge

    PTEN hamartoma tumor syndrome (PHTS) might be associated with a distinct cognitive and psychological profile. However, previous studies are limited, predominantly based on small and pediatric cohorts, likely affected by selection bias, and show a broad range of findings. We aimed to characterize the neuropsychological functioning of adults with PHTS. A total of 40 participants, with intellectual disability as exclusion criterium, completed an extensive clinical neuropsychological assessment including cognitive tasks, questionnaires, and a clinical diagnostic interview. The cognitive tasks and questionnaire data were categorized as below and above average based on 1.5 SD. About 80% of participants showed an average level of intelligence. In addition, 30% and 24% of participants scored below average on immediate memory recall and speed of information processing, respectively. Furthermore, about 25% reported above average scores on the majority of the questionnaires, indicating psychological distress, signs of alexithymia, and cognitive complaints. Personality of participants was characterized by inflexibility, social withdrawal, and difficulties in recognizing and describing their own emotions. Adults with PHTS demonstrate a heterogeneous yet distinct neuropsychological profile that is characterized by slower information processing, psychological problems, and specific personality traits. These findings provide directions on how to optimize the care and daily lives of adults with PHTS.


  • Detection and yield of thyroid cancer surveillance in adults with PTEN hamartoma tumour syndrome

    by Meggie M.C.M. Drissen, Janet R. Vos, Romana T Netea-Maier, Martin Gotthardt, Nicoline Hoogerbrugge

    Thyroid cancer surveillance (TCS) with ultrasound (US) is advised for PTEN hamartoma tumour syndrome (PHTS) patients due to increased thyroid cancer (TC) risk. However, data supporting TCS guidelines are scarce. We aimed to assess the detection and yield of annual TCS with US in adult PHTS patients without a TC history and to evaluate the impact of a reduced US interval on the TCS yield. A retrospective cohort study was conducted, including adult PHTS patients and medical record data between 2005 and 2021. The yield from annual TCS was compared with hypothetical biennial and triennial TCS after two initial US with annual interval by counting delayed detection of nodular growth, thyroid adenoma, and TC. During 279 follow-up years, 84 patients (median age 40 years) underwent 349 US. Thyroidectomy was performed in 6/84 (7%) patients, revealing a minimally invasive follicular TC in one patient aged 22 and a thyroid adenoma in two patients aged 21 and 53. Multiple thyroid nodules were diagnosed in 73/84 (87%) patients (median age 36 years). Nodular growth was detected in 9/56 (16%) patients, and its detection would have been delayed in 4–7% US rounds with biennial TCS, and in 2–6% US rounds with triennial TCS. US-based thyroiditis and indeterminate non-malignant lymph nodes were found in 8/74 (11%) and 7/72 (10%) patients, respectively. Following our findings combined with the literature, we propose starting TCS before age 18 and reducing the follow-up frequency after the initial two US from annual to biennial if no suspicious findings are detected.


  • Open Access

    Yield of annual endometrial cancer surveillance in women with PTEN Hamartoma Tumor Syndrome

    by Kevin J.J. Kwinten, Meggie M.C.M. Drissen, Joanne A. de Hullu, Janet R. Vos, Nicoline Hoogerbrugge, Anne M. van Altena


  • Open Access

    Red flags for early recognition of adult patients with PTEN Hamartoma Tumour Syndrome

    by Meggie M.C.M. Drissen, Jolanda H. Schieving, Janneke H.M. Schuurs-Hoeijmakers, Janet R. Vos, Nicoline Hoogerbrugge